vendredi 10 juin 2016

Home » » High-risk MS therapy gives trial subjects 'last shot at living'

High-risk MS therapy gives trial subjects 'last shot at living'

By  10:44  No comments
dr. freedman dr. atkins ms research ottawa hospital

New Canadian research led by two Ottawa doctors and published in The Lancet medical journal on Thursday suggests a high-risk therapy may stop multiple sclerosis from progressing, and even reverse the disease.



0 comments:

Enregistrer un commentaire